Roselabs Finance Limited has announced its unaudited financial results for the quarter ended December 31, 2025, showing improved performance with a narrowed net loss despite operational challenges. The Board of Directors approved these results at a meeting held on January 20, 2026, with statutory auditors MSKA & Associates LLP providing an unmodified opinion on the financial statements.

Financial Performance Overview

The company's financial performance for Q3FY26 demonstrated significant improvement compared to the corresponding quarter of the previous year:

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, Roselabs Finance showed considerable improvement in its financial position:

Expense Structure and Cost Management

The company's expense breakdown for Q3FY26 reveals the operational structure of its real estate development business. Cost of projects constituted the largest expense component at ₹119.55 crores, directly correlating with the revenue generation. Employee benefits expenses remained controlled at ₹1.25 crores, while other expenses totaled ₹3.62 crores, showing improved cost management compared to ₹9.89 crores in Q3FY25.

Corporate Developments

Roselabs Finance operates exclusively in the real estate development segment with operations confined to India. The company has no subsidiaries, joint ventures, or associate companies, eliminating the need for consolidated financial statements. A significant corporate development involves the proposed merger with Lodha Developers Limited (formerly Macrotech Developers Limited), which received BSE approval on December 30, 2025. The company is currently in the process of filing the merger application with the NCLT Mumbai Bench.

Capital Structure and Shareholding

The company maintains a stable capital structure with paid-up equity share capital of ₹1,000.00 crores, consisting of shares with a face value of ₹10 each. This capital base has remained unchanged across all reported periods, providing stability for the company's operations and strategic initiatives.

Regulatory Compliance and Audit Opinion

The financial results were prepared in accordance with Indian Accounting Standard 34 for Interim Financial Reporting and comply with SEBI Listing Regulations. The statutory auditors conducted their review in accordance with Standard on Review Engagement (SRE) 2410 and expressed an unmodified conclusion, indicating no material concerns with the financial statements' preparation and presentation.

Roselabs Finance Limited , a Mumbai-based financial services company, has announced the approval of its unaudited financial results for the second quarter and first half of the fiscal year 2026. The company's Board of Directors convened on October 17, 2025, to review and approve the financial statements.

Key Highlights

• Board Meeting Details:

  • Date: October 17, 2025
  • Commencement Time: 3:30 p.m. IST
  • Conclusion Time: 3:45 p.m. IST

• Financial Period: Quarter and half-year ended September 30, 2025

• Auditor: MSKA & Associates, Chartered Accountants

• Audit Opinion: Unmodified

Corporate Governance and Compliance

Roselabs Finance Limited has demonstrated its commitment to transparency and regulatory compliance by promptly submitting the approved results to BSE Limited. The company has also made the information available on its official website, ensuring easy access for shareholders and interested parties.

The approval of these financial results is in line with Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This adherence to regulatory standards underscores the company's dedication to maintaining good corporate governance practices.

Auditor's Review

MSKA & Associates, the statutory auditors of Roselabs Finance Limited, have provided a Limited Review Report accompanying the financial results. The unmodified opinion issued by the auditors suggests that the financial statements are free from material misstatements and comply with the applicable accounting standards.

While the specific financial figures have not been disclosed in the available information, the unmodified opinion from the auditors indicates a fair representation of the company's financial position for the period under review.

Investor Relations

Shareholders and potential investors can access the detailed unaudited financial results on the company's website at www.roselabsfinancelimited.in . This proactive approach to information dissemination aligns with best practices in investor relations and corporate transparency.

As the financial services sector continues to evolve, Roselabs Finance Limited's timely reporting and adherence to regulatory requirements position it as a company committed to keeping its stakeholders informed about its financial performance and corporate developments.